Outcomes of active cancer patients with COVID-19 infection treated with COVID-19 neutralizing monoclonal antibodies.

3137Background: Treatment with COVID-19 (C19) neutralizing monoclonal antibodies (mAbs), including bamlanivimab and casirivimab/imdevimab, has been associated with decreased rates of C19-related ho...